Carla Morales

Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma

Daruka Mahadevan, A Stejskal, Laurence Cooke et al. · Clinical Cancer Research · 2012 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer

Wenqing Qi, Carla Morales, Laurence Cooke et al. · Oncotarget · 2015 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2

Daruka Mahadevan, Carla Morales, Laurence Cooke et al. · PLoS ONE · 2014 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

Daruka Mahadevan, Noah Theiss, Carla Morales et al. · Oncotarget · 2014 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas

Shariful Islam, Wenqing Qi, Carla Morales et al. · Molecular Cancer Therapeutics · 2017 · 30 citations · Full text

Life Sciences, Cancer Biology, Oncology +17